[Effect of antitubercular agents on the development of aseptic inflammation].
D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000818:Animals; D000995:Antitubercular Agents / Q000627:therapeutic use*; D003523:Cycloserine / Q000627:therapeutic use; D003864:Depression, Chemical; D003911:Dextrans / Q000037:antagonists & inhibitors; D004195:Disease Models, Animal; D004487:Edema / Q000139:chemically induced / Q000517:prevention & control*; D005000:Ethionamide / Q000627:therapeutic use; D005122:Exudates and Transudates / Q000187:drug effects; D005557:Formaldehyde / Q000037:antagonists & inhibitors; D006099:Granuloma / Q000517:prevention & control*; D007249:Inflammation / Q000139:chemically induced / Q000517:prevention & control*; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D051381:Rats; D013268:Stimulation, Chemical; D013307:Streptomycin / Q000627:therapeutic use
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D003911:Dextrans; D005557:Formaldehyde; D003523:Cycloserine; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin
Vliianie protivotuberkuleznykh sredstv na razvitie asepticheskogo vespaleniia.